Stifel Financial’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Buy
11,469
+502
+5% +$162K ﹤0.01% 1587
2025
Q4
$3.33M Buy
10,967
+268
+3% +$87.7K ﹤0.01% 1577
2025
Q3
$3.65M Sell
10,699
-525
-5% -$159K ﹤0.01% 1480
2025
Q2
$2.72M Sell
11,224
-1,224
-10% -$300K ﹤0.01% 1627
2025
Q1
$3.39M Sell
12,448
-106
-0.8% -$24.8K ﹤0.01% 1407
2024
Q4
$2.32M Sell
12,554
-253
-2% -$51.7K ﹤0.01% 1666
2024
Q3
$2.88M Sell
12,807
-4,366
-25% -$786K ﹤0.01% 1545
2024
Q2
$2.45M Sell
17,173
-326
-2% -$50.2K ﹤0.01% 1586
2024
Q1
$2.74M Buy
17,499
+5,042
+40% +$812K ﹤0.01% 1509
2023
Q4
$2.25M Sell
12,457
-356
-3% -$64.4K ﹤0.01% 1584
2023
Q3
$2.3M Sell
12,813
-1,344
-9% -$266K ﹤0.01% 1499
2023
Q2
$2.52M Sell
14,157
-1,434
-9% -$330K ﹤0.01% 1454
2023
Q1
$3.36M Buy
15,591
+128
+0.8% +$30.7K ﹤0.01% 1259
2022
Q4
$3.4M Sell
15,463
-262
-2% -$48K 0.01% 1192
2022
Q3
$2.12M Sell
15,725
-69
-0.4% -$11.8K ﹤0.01% 1426
2022
Q2
$2.56M Buy
15,794
+506
+3% +$79K ﹤0.01% 1349
2022
Q1
$2.88M Buy
15,288
+1,213
+9% +$258K ﹤0.01% 1374
2021
Q4
$3.81M Buy
14,075
+191
+1% +$64.5K 0.01% 1216
2021
Q3
$5.04M Buy
13,884
+540
+4% +$177K 0.01% 1012
2021
Q2
$4.58M Buy
13,344
+145
+1% +$48K 0.01% 1067
2021
Q1
$4.59M Buy
13,199
+2,903
+28% +$961K 0.01% 1007
2020
Q4
$2.66M Sell
10,296
-863
-8% -$238K ﹤0.01% 1205
2020
Q3
$3.2M Buy
11,159
+2,095
+23% +$492K 0.01% 968
2020
Q2
$1.71M Sell
9,064
-703
-7% -$114K ﹤0.01% 1244
2020
Q1
$1.19M Buy
9,767
+174
+2% +$27.2K ﹤0.01% 1319
2019
Q4
$1.59M Sell
9,593
-129
-1% -$21.4K ﹤0.01% 1492
2019
Q3
$1.18M Buy
9,722
+4,567
+89% +$607K ﹤0.01% 1651
2019
Q2
$624K Buy
5,155
+21
+0.4% +$2.67K ﹤0.01% 2090
2019
Q1
$701K Buy
5,134
+1,301
+34% +$176K ﹤0.01% 1862
2018
Q4
$538K Buy
3,833
+282
+8% +$37.4K ﹤0.01% 1900
2018
Q3
$613K Buy
+3,551
New +$597K ﹤0.01% 1998

Other funds holding ONC

Stifel Financial's ONC Position: Q1 2026 in Review

Stifel Financial increased its BeOne Medicines Ltd (ONC) stake by 4.6% in Q1 2026, buying an estimated $162K and bringing the position to 11,469 shares worth $3.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1587.

Stifel Financial first reported a position in ONC in Q3 2018 and has held it in 31 quarters since. The position peaked at $5.04M in Q3 2021. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Stifel Financial held 11,469 shares of BeOne Medicines Ltd worth $3.41M as of Q1 2026.
  • Stifel Financial bought 502 BeOne Medicines Ltd shares in Q1 2026, an estimated $162K.
  • BeOne Medicines Ltd made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #1587 holding.
  • Stifel Financial first reported a position in BeOne Medicines Ltd in Q3 2018 and has held it in 31 quarters since.
  • Stifel Financial's BeOne Medicines Ltd position peaked at $5.04M in Q3 2021.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.